ReleaseWire Connect

The relative low cost and its abundance is prompting many countries to take advantage of coal as the major source for power generation in the coming years. However, the increasing fear of global warming and the impact of coal on our environment and on human health have led to calls for coal to be replaced by cleaner energy sources. These factors, together, are giving rise to the development of clean coal technology that aims to reduce the release of harmful by-products after combustion of coal. The clean coal technology market is expected to witness substantial growth over the next decade as many governments and private companies are investing in this growing market. Continuously growing demand for power, competitive position of coal, and the prospect of lower emissions from next generation technologies are boosting the market for clean coal.

Earlier medical nutrition solutions were meant for only to address malnutrition, but continued advancements in healthcare has led to the use of these medicated foods to complement drugs to treat various diseases such as diabetes, obesity, renal failure, pediatric malnutrition, sarcopenia and cancer. These medicated nutritional products are segmented into pediatric nutrition, elderly nutrition, sports nutrition and parenteral nutrition. Some of the commercially available medical nutrition products are Elecare for kids and EAS for athletes marketed by Abbott Nutrition and Souvenaid and FortFit marketed by Nutricia. Parenteral nutrition is feeding a person by means of intravenous, it is given only when a patient is on hemodialysis and is unable to manage adequate nutrition. Usually glucose, proteins, electrolytes and vitamins are administered through parenteral route.

Microencapsulation has been used across various industries since many years including agrochemical, pharmaceutical, food, paper industry and textiles. Microencapsulation is a process of coating small droplets or particles with a continuous film of polymeric material to produce small capsules known as microcapsules. There are many reasons behind encapsulation, some of them includes isolation from the surrounding, preventing evaporation of volatile substance, avoid unnecessary chemical attack on reactive materials and handling sticky material. In pharmaceutical industry, it has revolutionized the development of drug delivery by providing protection to encapsulated active ingredients against degradation and ensuring sustained release of drugs. Other advantages include masking the bitterness of certain drugs, targeted delivery to specific sites and ability to reduce adverse effects associated with some drugs. Most commonly used techniques for microencapsulation are chemical, physiochemical and electrostatic and mechanical processes. Chemical method involves in situ polymerization while physiochemical process includes separation based on coacervation phase, complex emulsion and dispersion. Pan coating, spray drying and bed granulator are the types of mechanical processes. Micro-K containing potassium chloride is encapsulated to enhance its release.

Biological drugs are biological medical products whose active drug substance is extracted by using living organism. The active substance is derived from living organism by the usage of recombinant DNA technology. These drugs offer better treatment solutions than synthetic drugs owing to greater accuracy and fewer side effects. Biological drugs are mainly made of monoclonal antibodies (mAbs) that help to fight with the disease. Monoclonal antibodies have the capability of targeting specific area in the body that requires drug treatment hence producing accurate results. Majorly biologic drugs are given for the treatment of diseases such as HIV/AIDS, Alzheimer’s diseases, cancers and others. Moreover, biologic drugs are also expected to find a solution for the large portion of retired population which is more prone to chronic diseases.

An oxygen concentrator is a device used to deliver concentrated oxygen to a patient requiring oxygen therapy. These devices are considered as a safer, easy to use and inexpensive compared to compressed oxygen cylinders. Portable oxygen concentrator is useful to people using oxygen tanks as a constant supply of oxygen by enabling them mobility. Portable oxygen concentrator acts by increasing the concentration of oxygen by taking a mixture air from its surrounding. Airstep Freestyle, Inogen One G2, Invacare XPO2 and DeVilbiss iGo are some the commercially available portable oxygen concentrators. These devices are also used by mountaineers and people travelling to places where oxygen is inadequate amount.

Isopropyl-benzene is commonly called as Cumene which is an organic compound generally based on aromatic hydrocarbons with aliphatic substitution. Cumene is a colorless, flammable liquid and having boiling point of 152°C is a constituent of refined fuels and crude oil. Cumene is stable material but shows little instability forming peroxides while storage when comes in contact of air. Industrially cumene is produced by Friedel–Crafts alkylation between benzene and propylene. Mostly cumene is converted to an intermediate called cumene hydroperoxide for further applications.

Coronary Artery Bypass Graft (CABG) is most common type of heart surgery that is performed to treat people suffering from severe angina and coronary artery heart disease. In coronary heart disease, a plaque is formed inside the coronary artery that carries oxygenated blood to myocardium. As the plaque becomes harder over the time, it narrows down the artery and subsequently causes reduced blood flow to heart leading to chest pain called angina. In CABG, a healthy artery or vein from elsewhere in the body is grafted to blocked coronary artery that facilitates the flow of oxygenated blood to heart muscles. Depending on the number of coronary arteries bypassed, the surgery is referred as single bypass, double bypass, triple bypass and quadruple bypass. Usually, there are two different methods to perform CABG namely on-pump CABG and off-pump CABG. Some minimally invasive coronary artery bypass (MIDCAB) surgeries are also performed such as endoscopic or thoracoscopic and robotic assisted surgery that include smaller incision, less bleeding, low risk of infection and reduced recovery time. Some of the commercially available devices used in CABG are OPTrac STILLSITE Stabilizer by Heartport, Ultima OPCAB system by Guidant and OCTOPUS 2+ Tissue Stabilization System by Medtronics. Some of the prominent vendors operating in this market are Sorin Group, Heratport, MAQUET, Guidant, Medtronic and Terumo.

This report provides an in-depth analysis and market forecast for the global pharmacy automation market for the period 2012 – 2018. The report provides details of the several pharmacy automation devices currently available in the market along with the impact of these machines on modern pharmacies in terms of efficiency, reduction in error and speed. The report also highlights the unique connection of pharmacy automation devices with a number of other markets such as the E-prescription market and its role in the growth of pharmacy automation.

This report provides an in-depth analysis and market forecast for the global pharmacy automation market for the period 2012 – 2018. The report provides details of the several pharmacy automation devices currently available in the market along with the impact of these machines on modern pharmacies in terms of efficiency, reduction in error and speed. The report also highlights the unique connection of pharmacy automation devices with a number of other markets such as the E-prescription market and its role in the growth of pharmacy automation.

The cell culture market is experiencing impressive growth globally because of the tremendous increase in demand for biopharmaceutical products. Since its introduction as an integral part of the life science industry, the cell culture market has experienced huge growth in terms of scope as well as adoption by end users. The rapid double-digit growth in biotechnology and biopharmaceutical industries is slated to be the major driving force for the growth of the cell culture market in the future.